84 related articles for article (PubMed ID: 16978268)
1. Low penetrance genetic susceptibility to kidney cancer.
Thibault F; Cancel-Tassin G; Cussenot O
BJU Int; 2006 Oct; 98(4):735-8. PubMed ID: 16978268
[No Abstract] [Full Text] [Related]
2. Conventional renal cancer in a patient with fumarate hydratase mutation.
Lehtonen HJ; Blanco I; Piulats JM; Herva R; Launonen V; Aaltonen LA
Hum Pathol; 2007 May; 38(5):793-6. PubMed ID: 17270241
[TBL] [Abstract][Full Text] [Related]
3. SDHB--a gene for all tumors?
Eng C
J Natl Cancer Inst; 2008 Sep; 100(17):1193-5. PubMed ID: 18728280
[No Abstract] [Full Text] [Related]
4. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
Varol A; Stapleton K; Roscioli T
Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility to prostate cancer.
Cancel-Tassin G; Cussenot O
BJU Int; 2005 Dec; 96(9):1380-5. PubMed ID: 16287462
[No Abstract] [Full Text] [Related]
6. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
7. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726
[TBL] [Abstract][Full Text] [Related]
8. Pathologic features of renal cortical tumors.
Tickoo SK; Gopalan A
Urol Clin North Am; 2008 Nov; 35(4):551-61; v. PubMed ID: 18992609
[TBL] [Abstract][Full Text] [Related]
9. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
Riemann K; Becker L; Struwe H; Nückel H; Dührsen U; Alakus H; Winde G; Neuhäuser M; Rübben H; Schmitz KJ; Wohlschlaeger J; Schmid KW; Siffert W
Pharmacogenet Genomics; 2006 Nov; 16(11):783-8. PubMed ID: 17047486
[TBL] [Abstract][Full Text] [Related]
10. [The dog: is it the future of cancer genetics?].
Parodi AL
Rev Prat; 2001 Mar; 51(6):585-6. PubMed ID: 11345857
[No Abstract] [Full Text] [Related]
11. Renewed hope for patients with advanced renal cell cancer: Cinderella comes of age.
Eisen T
Eur J Cancer; 2005 May; 41(8):1106-8. PubMed ID: 15911232
[No Abstract] [Full Text] [Related]
12. [Familial cutaneous and uterine leiomyomatosis].
Marque M; Avril MF; Bressac de Paillerets B; Guillot B; Richard S; Bessis D
Ann Dermatol Venereol; 2008; 135(8-9):612-6. PubMed ID: 18789302
[No Abstract] [Full Text] [Related]
13. Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunities.
Hansel DE; Rini BI
Expert Rev Anticancer Ther; 2008 Jun; 8(6):895-905. PubMed ID: 18533799
[TBL] [Abstract][Full Text] [Related]
14. Hereditary and familial kidney cancer.
Coleman JA; Russo P
Curr Opin Urol; 2009 Sep; 19(5):478-85. PubMed ID: 19584731
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary forms of kidney cancer and genetic screening].
Valeri A; Cussenot O
Prog Urol; 2003 Nov; 13(5 Suppl 2):1201-4. PubMed ID: 15816384
[No Abstract] [Full Text] [Related]
16. Renal cancer: Genetic directed therapy.
Loughlin KR
Urol Oncol; 2009; 27(2):130. PubMed ID: 19285229
[No Abstract] [Full Text] [Related]
17. Searching for the hereditary causes of renal-cell carcinoma.
Pavlovich CP; Schmidt LS
Nat Rev Cancer; 2004 May; 4(5):381-93. PubMed ID: 15122209
[No Abstract] [Full Text] [Related]
18. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
Romero JM; Sáenz-López P; Cózar JM; Carretero R; Canton J; Vazquez F; Concha A; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2009 Jan; 70(1):60-4. PubMed ID: 19027043
[TBL] [Abstract][Full Text] [Related]
19. Hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report.
Hayedeh G; Fatemeh M; Ahmadreza R; Masoud A; Ahmad S
Dermatol Online J; 2008 Jan; 14(1):16. PubMed ID: 18319033
[TBL] [Abstract][Full Text] [Related]
20. Multiple leiomyoma as a possible sign of aggressive renal cancer.
Chia MW; Tay YK; Tan SH
Int J Dermatol; 2008 Nov; 47(11):1157-8. PubMed ID: 18986449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
